Rade Tomic, MD

Associate Professor of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine

Rade Tomic

Contact Info

Mailing Address:
Division of Pulmonary, Allergy, Critical Care and Sleep Medicine
420 Delaware Street SE
MMC 276 (Pulmonary)
MMC 434 (Allergy)
Minneapolis, MN 55455

Administrative Assistant Name
PACCS

Administrative Phone
612-624-0999

Administrative Email
paccmed@umn.edu

Administrative Fax Number
612-625-2174

Associate Professor of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine


Pulmonologist, Critical Care Physician


Medical School Zagreb, Zagreb, Croatia

Residency, University of Illinois, Chicago, IL

Fellowship, Emory University, Atlanta, GA

Summary

I am involved in the care of patients with any pulmonary disorders and I am also attending in Medical Intensive Care Unit. However, the focus of my clinical activities and interests is directed toward patients with Interstitial Lung Diseases and patients requiring lung transplantation.

Awards & Recognition

  • Best Doctors in USA (2011-2012)
  • Trainee Award for best original research, Southern Society of Clinical Investigation, New Orleans, LA (2004)
  • Chest Challenge National Finalist, American College of Chest Physicians, Orlando, FL (2003)
  • Robert A. Weinstein award for Resident Teacher of the Year given for remarkable knowledge and extraordinary talent in the art of teaching, Michael Reese Hospital, Department of Medicine, Chicago, IL (2001)

Research

Research Summary/Interests

  • A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of GS-6624 in Subjects with Idiopathic Pulmonary Fibrosis (RAINIER) Co-Investigator, 2013-2016
  • An Open-Label Extension Study of the Long-Term Safety of Pirfenidone in patients with Idopathic Pulomonary Fibrosis (IPF) Who Complete the CAPACITY Studies Co-investigator, Intermune 2012-2013
  • PIPF-106 entitled “A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of the Efficacy and Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis” Co-investigator, Intermune 2012-2013
  • Randomized, double-blind, placebo-controlled study of the safety, tolerability,pharmacokinetics and pharmacodynamics of ascending repeated doses of SAR156597 in patients with idiopathic pulmonary fibrosis, Co-investigator, Sanofi 2012-2013
  • A Prospective longitudinal non-pharmacological case controlled study to evaluate longitudinal disease behavior and biomarker data over 52-week period in patients with Idiopathic Pulmonary Fibrosis ASY 122995, Principal Investigator, Sanofi 2012-2013

Publications

PubMed Publication List

  1. Air in the Left Ventricle. An Unusual Case of Endocarditis. Kesler S, Kim H, Perlman D, Dincer HE, Thenappan T, Tomic R.Am J Respir Crit Care Med. 2016 May 15;193(10):1176-7. doi: 10.1164/rccm.201506-1156IM. No abstract available.
  2. Novel mechanisms and treatment of idiopathic pulmonary fibrosis. Elmufdi F, Henke CA, Perlman DM, Tomic R, Kim HJ.Discov Med. 2015 Sep;20(109):145-53. Review.
  3. Cognitive function in idiopathic pulmonary fibrosis.Bors M, Tomic R, Perlman DM, Kim HJ, Whelan TP.Chron Respir Dis. 2015 Nov;12(4):365-72. doi: 10.1177/1479972315603552.

Clinical

Specialties

  • Critical Care Medicine
  • Internal Medicine
  • Pulmonology

Board Certifications

Pulmonary and Critical Care Medicine

Clinical Interests

Idiopathic Pulmonary Fibrosis; Lung Transplantation; Radiation Pneumonitis; Interstitial Lung Diseases